Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to temperature regulation. The once-daily pill came from Bayer’s 2020 acquisition of KaNDy Therapeutics.
The post Bayer Menopause Drug Lands FDA Approval, Bringing Competition to an Astellas Product appeared first on MedCity News.
